Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
03/2005
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512678A1 Process for preparing optically active nitro compounds and cyano compounds
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1307440B1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/09/2005CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/09/2005CN1192449C New electrolytes and lithium ion battery using the same
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864225 Cyclic ketals, fragrance compositions containing the same and methods of using the same
03/03/2005WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
03/03/2005WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors
03/03/2005WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF
03/03/2005US20050049278 Anticarcinogenic agents; synthesis
03/03/2005US20050049235 Amino ceramide-like compounds and therapeutic methods of use
03/03/2005US20050048395 Homopolymer or copolymer of polyhydroxystyrene changes its solubility in an alkali developer by action of an acid; generating an acid by exposure to radiation; bis((4-(1,3-dioxolan-2-yl)cyclohexyl)methylsulfonyl)diazomethane
03/02/2005EP1510512A1 Process for producing alicyclic aldehydes
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509188A2 Compounds active at the glucocorticoid receptor ii
03/02/2005EP1392650B1 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2- ?18 f]-fluoroethyl)-l-tyrosine
03/02/2005EP1077698B1 Metabolites of ecteinascidin 743
03/02/2005EP1042279B1 Substituted beta-alanines
03/02/2005CN1191232C Aminomethylcarboxylic acid derivatives
03/01/2005US6861564 Process for preparing resorcinol derivatives
03/01/2005US6861537 Tricyclic and tetracyclic taxane intermediates
02/2005
02/24/2005WO2005016867A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome
02/24/2005US20050043370 Therapy for acquired immune deficiency or aids related complex; compound containing ketone and carboxy groups
02/24/2005US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor
02/24/2005US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis
02/24/2005US20050043299 Inhibitors of dipeptidyl peptidase iv
02/24/2005US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
02/23/2005EP1507541A2 Inhibitors and methods of use thereof
02/23/2005EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method
02/23/2005EP0916654B1 Sulfonic ester derivatives, process for preparing the same, and use thereof
02/23/2005CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases
02/23/2005CN1583738A Synthesis of 4, 5-dimethyl-1, 3-dioxane amylene-2-one
02/22/2005US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors
02/22/2005US6858648 Laetispicine and laetispicine analogues, methods of use and preparation
02/22/2005CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
02/17/2005WO2005015158A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
02/17/2005WO2005013928A1 Composition and method for promoting hair growth
02/17/2005WO2004093781A3 Podophyllotoxin derivatives as igf-1r inhibitors
02/17/2005WO2004092115A3 Hydroxamates as therapeutic agents
02/17/2005WO2003099192A8 Bis-aromatic alkanols
02/17/2005US20050038266 Method for producing glycerol carbonate
02/17/2005US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization
02/17/2005US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide
02/17/2005US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
02/17/2005DE10333368A1 Multifunktionell-verknüpfungsfähige und spaltbare Festphasenreagenzien und Verfahren zu deren Herstellung Multi-functional-link-able and cleavable solid phase reagents and methods for their preparation
02/17/2005CA2535045A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
02/17/2005CA2534645A1 Composition and method for promoting hair growth
02/16/2005EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
02/16/2005EP1506158A2 Diamino-functional chalcones
02/16/2005EP1506157A2 Amino-functional chalcones
02/16/2005EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
02/16/2005EP1068200B1 2,4,4-trisubstituted-1,3-dioxolane antifungals
02/16/2005EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
02/16/2005CN1580053A Method for purifying piperonyl butoxide synthesized from sassafras oil
02/16/2005CN1189246C High activity catalyzed to utilzed to synthesize cyclic carbonate
02/15/2005US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders
02/15/2005US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
02/15/2005US6855821 Processes for preparing 1,3-dioxolane nucleosides
02/15/2005US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants
02/10/2005WO2005012280A1 Alkynyl aryl carboxamides
02/10/2005WO2004077511A3 (meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
02/10/2005US20050033090 Process for the preparation of cinnamaldehyde compounds
02/10/2005US20050033081 Treating an animal for parasites
02/10/2005US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines
02/10/2005DE10333379A1 Acetale, ihre Verwendung als Reichstoffe und Verfahren zu ihrer Herstellung Acetals, their use as Reich materials and processes for their preparation
02/10/2005CA2527861A1 Alkynyl aryl carboxamides
02/09/2005EP1505054A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
02/09/2005EP1503981A2 Substituted tetracycline compounds
02/09/2005EP1503761A1 Substituted piperazines as melanocortin receptor ligands
02/09/2005EP1175382B1 Method for the dihydroxylation of olefins using transition-metal catalysts
02/09/2005CN1578792A Fulvene, metallocene catalysts and preparation method thereof, and preparation of polyolefines copolymer using the same
02/09/2005CN1578783A Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
02/09/2005CN1578663A Inhibitors of histone deacetylase
02/09/2005CN1576360A Acetonide fragrance compound
02/09/2005CN1188392C Process for synthesis of hydrocarbonfluoride
02/08/2005US6852723 Aralkyl substituted piperazine compounds
02/03/2005WO2005010131A1 Method for producing an oxygen-containing compound used as fuel additive, in particular in diesel fuels, gasoline and rapeseed methyl ester
02/03/2005WO2005009984A1 Acetals, use thereof as fragrances and methods for production thereof
02/03/2005WO2005009981A1 Multifunctional linking and cleavable solid-phase reagents and method for the production thereof
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke
02/03/2005US20050026785 Novel phenyl-propargylether derivatives
02/03/2005US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/03/2005CA2530219A1 Method for producing an oxygen-containing compound used as fuel additive, in particular in diesel fuels, gasoline and rapeseed methyl ester
02/02/2005EP1502908A1 Process for fluorurating ethers
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 183